Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:        
Net loss for the period $ (5,522) $ (2,640) $ (22,604) $ (8,373)
Items not involving cash:        
Stock-based compensation 952 156 3,695 666
Shares issued to Aspire Capital as commitment fees (note 6(a)(iii)) 600
Depreciation and amortization 29 20 64 66
Interest income (80) (21) (198) (40)
Unrealized foreign exchange (loss) gain (28) (48) (2) (98)
Change in non-cash operating working capital (note 8) 101 442 542 395
Cash used in operating activities (4,548) (2,091) (17,903) (7,384)
Cash flows from financing activities:        
Issuance of common shares under the 2018 ATM, net of issuance costs (note 6(a)(i)) 1,572 6,818
Issuance of common shares under Share Purchase Agreement (note 6(a)(ii)) 14,995
Issuance of common shares under the ATM, net of issuance costs (note 6(a)(iv)) 1,999 10,203
Issuance of common shares upon exercise of stock options (note 7) 36 219
Cash provided by financing activities 1,608 1,999 22,032 10,203
Cash flows from (used in) investing activities:        
Maturity (acquisition) of investments (9) 250 (2,994)
Purchase of property and equipment (28) (152)
Interest received 80 21 198 40
Cash provided by (used in) investing activities 52 12 296 (2,954)
Effect of exchange rate fluctuations on cash and cash equivalents held 48 98
Increase (decrease) in cash and cash equivalents (2,888) (32) 4,425 (37)
Cash and cash equivalents, beginning of period 17,944 7,935 10,631 7,940
Cash and cash equivalents, end of period $ 15,056 $ 7,903 $ 15,056 $ 7,903